This page includes the latest FDA filings for Mallinckrodt Ard L L C. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Mallinckrodt ARD LLC, Cangene BioPharma, LLC | Prescription Medication | 2024-07-19 |
Mallinckrodt ARD LLC, Cangene BioPharma, LLC | Prescription Medication | 2024-06-19 |
Mallinckrodt ARD LLC, Cangene BioPharma, LLC | Prescription Medication | 2023-10-30 |
Mallinckrodt ARD LLC, Cangene BioPharma, LLC | Prescription Medication | 2023-03-23 |
Mallinckrodt ARD LLC, Cangene BioPharma, LLC | Prescription Medication | 2022-02-25 |
Mallinckrodt ARD LLC, Cangene BioPharma, LLC | Prescription Medication | 2021-11-09 |
Mallinckrodt ARD LLC, Cangene BioPharma, LLC | Prescription Medication | 2021-06-17 |
Mallinckrodt ARD LLC, Cangene BioPharma, LLC | Prescription Medication | 2021-03-13 |
Mallinckrodt ARD LLC, Cangene BioPharma, LLC | Prescription Medication | 2020-03-27 |
Mallinckrodt ARD LLC, Cangene BioPharma, LLC | Prescription Medication | 2019-04-12 |
Mallinckrodt ARD LLC | Acthar | 2013-01-07 |
NCAGE Code | 3WTV6 | MALLINCKRODT ARD LLC |
CAGE Code | 3WTV6 | MALLINCKRODT ARD LLC |
S.A.M. Registration | 3WTV6 [625130828] | MALLINCKRODT ARD LLC |